肝素/聚乙烯醇凝胶灌注修饰的小口径膨体聚四氟乙烯人工...

PTFE

肝素/聚乙烯醇凝胶灌注修饰的小口径膨体聚四氟乙烯人工血管
Small-caliber expanded poly（tetrafluoroethylene） vascular prosthesis impregnated with heparin and polyvinyl alcohol gel
作　　者：马艳[1] 岳秀丽[2] 刘萌[1] 刘绍琴[1] 戴志飞[1]

Ma Yan, Yue Xiu-li, Liu Meng, Liu Shao-qin, Dai Zhi-fei（1Nanomedicine and Bioscasor Lab, Biomedical Engineeing Ceater, Harbin Institute of Technology, Harbin 150080,Heilongjiang Province China; 3.College of Urdan Water Resources and Environment, Harbin Institur of Technology, Harbin 150001, Heilongjiang Province, China）

机构地区：[1]哈尔滨工业大学生物医学工程中心纳米医药与生物传感器实验室,黑龙江省哈尔滨市150080 [2]哈尔滨工业大学市政与环境工程学院,黑龙江省哈尔滨市150001

出　　处：《中国组织工程研究与临床康复》 CAS CSCD 2008年第12卷第14期 2773-2776页,共4页

Journal of Clinical Rehabilitative Tissue Engineering Research

基　　金：国家自然科学基金资助项目（NSFC-50573015）.新世纪优秀人才支持计划资助项目

摘　　要：背景：小口径（直径小于6mm）膨体聚四氟乙烯人工血管由于血栓形成和内膜增生等原因,在冠状和外周血液循环中的应用受到了限制,而生物活性表面肝素涂层是解决上述问题的一条有效途径。目的：为了提高膨体聚四氟乙烯人工血管的抗凝血性能,采用新型肝素涂层——共价交联的聚乙烯醇/重氮树脂/肝素凝胶修饰小口径膨体聚四氟乙烯人工血管以提高其通畅性,并观察其血液相容性。设计、时间及地点：观察性实验,于2006-05/2007-06在哈尔滨工业大学生物医学工程中心的纳米医药与生物传感器实验室完成。材料：膨体聚四氟乙烯人工血管（直径4mm）,全氟磺酸和聚乙烯醇购于美国Aldrich公司,肝素购于Calbiochem公司（MW12000~14000）,重氮树脂由实验室自己合成。方法：①用全氟磺酸修饰膨体聚四氟乙烯表面。②用聚乙烯醇/重氮树脂/肝素凝胶进行灌注修饰,在紫外光照射的条件下,重氮树脂作为交联剂,将肝素和聚乙烯醇分子进行共价交联。主要观察指标：①接触角。②衰减全反射-傅里叶变换红外光谱表征材料表面的化学结构。③活化部分凝血激酶时间、凝血酶原时间。④溶血试验。⑤血小板黏附试验。⑥凝血酶失活试验。结果：①修饰后的人工血管的接触角降低,衰减全反射-傅立叶变换红外光谱显示在2172cm-1和2224cm-1处出现了重氮基团的特征峰位。②与未修饰的人工血管相比,修饰后的人工血管具有较长的活化部分凝血激酶时间和凝血酶原时间、较低的溶血度、很少数量的血小板黏附。③与未修饰的人工血管相比,修饰后的人工血管对凝血酶的活性有较强的抑制作用,且涂层稳定。结论：聚乙烯醇/重氮树脂/肝素凝胶形成的肝素涂层不仅具有很好的抗血栓形成的性能,而且具有较低的溶血度,因此显著提高了人工血管的血液相容性。

BACKGROUND： Thrombus formation and neointimal hyperplasia still limit the use of small-caliber expanded poly（tetrafluoroethylene） （ePTFE） vascular prosthesis with a diameter less than 6 mm for revascularization in the coronary or peripheral circulation. Bioactive surface heparin coating is one conceivable path for above-mentioned problems. OBJECTIVE： To elevate the anticoagulant property of ePTFE, this study promoted the patency of a novel small-caliber ePTFE vascular graft by modifying its luminal surface with covalently crosslinked poly（vinyl alcohol）/ p-diazonium diphenyl amine polymer/heparin gel （PVA/PA/Hep gel） and examined the hemocompatibility of the graft. DESIGN, TIME AND SETTING： Observational experiments were performed at the Nanomedicine and Biosensor Lab, Biomedical Engineering Center, Harbin Institute of Technology from May 2006 to June 2007. MATERIALS： The ePTFE vascular grafts （diameter of 4 mm）, Nation （Naf） and Poly（vinyl alcohol） （Aldrich, USA）, heparin （Mw 12 000-14 000） （Calbiochem, USA）, p-diazonium diphenyl amine polymer （PA） （this lab, China） were used in this study. METHODS： （1）The vascular graft surface was firstly modified with Nation. （2）Following the impregnation of the mixture of PVA/PA/Hep, covalent crosslinking between polyvinyl alcohol and heparin was performed using crosslinker PA under ultraviolet radiation. MAIN OUTCOME MEASURES： （1）Contact angles, （2）Attenuated total reflection-fourier transform infrared spectroscopy （ATR-FTIR）, （3）Activated partial thromboplastin time （APTT） and prothrombin time （PT）, （4）hemolysis test, （5）platelet adhesion test and （6）thrombosin inactivation test. RESULTS： （1）The water contact angle of the vascular graft surface was greatly decreased after modifying. ATR-FTIR revealed the disappearance of diazonium groups at 2 172 cm^-1 and 2 224 cm^-1. Vascular prosthesis after modifying had prolonged APTT and PT, low percent hemolysis and low amount of platelet adhesion. Modified vascular prosthesis had inhibitory effect on thrombosin activity and good coating stability. CONCLUSION： Converage of PVA/PA/Hep has good antithrombotic function and low percent hemolysis, resulting in improving hemocompatibility of vascular prosthesis.

关 键 词：膨体聚四氟乙烯人工血管 共价交联 抗凝血表面修饰 血液相容性
分 类 号： R318.08 [医药、卫生 > 基础医学 > 医用一般科学 > 生物医学工程 > 一般性问题]

参考文献作者在撰写文献时引用的其他文献，反映本文的背景或依据。 (16篇)[1]Tseng DY, Edelman ER. Effects of amide and amine plasma-treated ePTFE vascular grafts on endothelial cell lining in an artificial circulatory system. J Biomed Mater Res 1998,42(2): 188-198.
[2]Kito H, Matsuda T. Biocompatible coatings for luminal and outer surfaces of small-caliber artificial grafts. J Biomed Mater Res 1996, 30(3):321-330.
[3]Guidoin R, Marceau D, Couture J, et al. Collagen coatings as biological sealants for textile arterial prostheses. Biomaterials 1989, 10(3):156-165.
[4]Chvapil Y, Na M. Healing pattern of collagen-impregnated and preclotted vascular grafts in dogs. Vasc Surg 1987,21:401-411.
[5]Zhu AP, Zhang M, Zhang Z. Surface modification of ePTFE vascular grafts with O-carboxymethylchitosan. Polym Int 2004,53(1): 15-19.
[6]Tumer RF, Harrison D J, Rajotte RV. Preliminary in vivo biocompatibility studies on perfluorosulphonic acid polymer membranes for biosensor applications. Biomaterials 1991,12(4):361-368.
[7]Ritter EF, Fata MM, Rudner AM,et al. Heparin bonding increases patency of long microvascular prostheses, Plast Reconstr Surg 1998, 101(1): 142-146.
[8]Chung YI, Tae G, Yuk SH. A facile method to prepare heparin-functionalized nanoparticles for controlled release of growth factors. Biomaterials 2006,27(12):2621-2626.
[9]Houska M, Bryntla E, Bohata K. The effect of polyelectrolyte chain length on layer-by-layer protein/polyelectrolyte assembly-an experimental study. J Colloid Interface Sci 2004, 273(1): 140-147.
[10]Tan Q, Ji J, Barbosa MA,et al. Constructing thromboresistant surface on biomedical stainless steel via layer-by-layer deposition anticoagulant. Biomaterials 2003,24 (25):4699-705.
[11]Nojiri C, Okano T, Park KD,et al. Suppression mechanisms for thrombus formation on heparin-immobilized segmented polyurethane-ureas. ASAIO Trans 1988,34(2):386-398.
[12]Zhao C, Chen JY, Cao WX. Synthesis and characterization of diphenylamine diazonium salts and diazoresins. Angewandte Makromolekulare Chemie 1998:259:77-82.
[13]Liu M, Yue XL, Dai ZF, et al. Stabilized Hemocompatible Coating of Nitinol Devices Based on Photo-Cross-Linked Alginate/Heparin Mutilayer. Langmuir 2007,23:9378-9385.
[14]Yamada K, Iizawa Y, Yamada J,et al. Retention of activity of urease immobilized on grafted polymer films.J Applied Polym Sci 2006, 102(5):4886-4896.
[15]Williams SK, Kleinert LB, Hagen KM,et al. Clapper. Covalent modification of porous implants using extracellular matrix proteins to accelerate neovascularization. J Biomed Mater Res A 2006,78(1):59-65.
[16]Yue XL, Tian W J, Yang JZ, et al. Covalently-attached heparin multilayer coatings on the luminal surface of silicone-coated vascular graft. Acta Chim Sinica 2007,65(4):367-372.